chet123's blog

The global robotic prosthetic market size is expected to reach USD 2,384.4 Million in 2028 and register a revenue CAGR of 8.9% over the forecast period, according to latest report by Reports and Data. Emergence of mind-controlled humonics is considered one of the most important factors to impact market revenue growth.

Furthermore, rising cases of injuries, road accidents, and growing incidence of chronic diabetes are increasing the number of amputation surgeries being carried out. Robotic prosthetic helps to restore lost functions of missing body parts, along with improving aesthetic appearance. The kind of prosthetic to be used depends on size, type, use, and steadiness and age of the individual. People are increasingly opting for personalized robotic prosthetic, which is expected to increase their demand and thus, drive market growth during the forecast period.

Increasing expenditure on research & development to incorporate smart mechatronics and sophisticated sensing and control for achieving lost sensorimotor functions is enabling incorporation of modern technology in devices. This is generating growth opportunities in the global market.

To receive a sample copy of the global Robotic Prosthetic Market report, visit @ https://www.reportsanddata.com/download-summary-form/4913

Robotic prosthetic is not covered under insurance policies in some countries, which may restrict growth of the market. Moreover, robotic prosthetic products are costly, which makes them out of reach to a large section of the population. This may also hamper market growth over the forecast period.

Top Companies Profiled in the Report Include:

• Artificial Limbs and Appliances
• Endolite
• Hansen Medical Inc.
• HDT Global Inc.
• Open Bionics
• Ottobock
• Ossur
• ReWalk Robotics
• Smith & Nephew
• SynTouch Inc.
• The Shadow Robot Company
• Touch Bionics.

Robotic Prosthetic Market Overview:

The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.   

Some Key Highlights From the Report -

• By application, lower body extremities segment accounted for largest revenue share in 2020. Wide accessibility of lower body extremity devices, launch of new and advanced robotic prosthetic products, and rise in the number of people with lower body amputation are factors driving growth of this segment.
• By end-use, hospital segment accounted for largest revenue share in 2020. Growth of this segment can be attributed to rising cases of severe injuries and road accidents across the globe. Increase in the number of patients suffering from physical trauma, adoption of advanced technologies around the world, and sustainable reimbursement policies are also contributing to market growth.
• Demand for robotic prosthetic is increasing due to its ability to make a limb function normally after the loss of the natural limb. Increasing prevalence of various diseases that result in loss of limb is driving market growth.
• Robotic prosthetic market in North America accounted for largest revenue share in 2020, which can be attributed to factors such as increasing expenditure on healthcare, increasing number of hospitals, and advancement in robotics technology used in robotic prosthetic. Government initiatives to advance robotic technology and prevent amputations are also expected to support regional market growth.

To receive a flat discount on the Robotic Prosthetic Market report, visit @ https://www.reportsanddata.com/discount-enquiry-form/4913

For this report, Reports and Data has segmented the global robotic prosthetic market based on product type, technology, end-use, application, and region:  

Product Type Outlook (Revenue, USD Million; 2018-2028)

• Prosthetic Arms
• Prosthetic Ankle/Feet
• Prosthetic Knees
• Prosthetic Hands
• Others

Technology Outlook (Revenue, USD Million; 2018-2028)

• Bluetooth
• Microprocessor
• Myoelectric Technology
• Targeted Muscle Reinnervation

Application Outlook (Revenue, USD Million; 2018-2028)

• Upper Body Extremities
• Lower Body Extremities

End-Use (Revenue, USD Million; 2018-2028)

• Hospitals
• Ambulatory Surgical Centers
• Clinics

Key Regional Markets Studied in the Report:

• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• The Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Have A Look For Related Reports:

Glucose Meter Market @ https://www.biospace.com/article/glucose-meter-market-revenue-driven-by-growing-awareness-regarding-self-management-of-diabetes-reports-and-data/

Cell Therapy Market @ https://www.biospace.com/article/cell-therapy-market-revenue-driven-by-advancements-in-cell-therapy-and-rising-demand-for-regenerative-medicine-reports-and-data-/

Heparin Market @ https://www.biospace.com/article/heparin-market-revenue-growth-driven-by-growing-prevalence-of-chronic-and-acute-diseases-worldwide-reports-and-data-/

Healthcare Analytical Testing Services Market @ https://www.biospace.com/article/healthcare-analytical-testing-services-market-to-reach-usd-11-9-billion-by-2028-says-reports-and-data/

Microscope Software Market @ https://www.biospace.com/article/microscope-software-market-to-reach-usd-1-490-0-million-by-2028-says-reports-and-data/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:                       

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

To know more about the Robotic Prosthetic Market report @ https://www.reportsanddata.com/report-detail/robotic-prosthetic-market

The Oxycodone Market is estimated to grow from USD 5.23 Billion in 2020 to USD 7.46 Billion by 2028, at a CAGR of 4.6%, during the forecast period. The oxycodone market is driven by an increase in the number of patients suffering from terminally ill diseases such as cancer and HIV and a high increase in the prescription of post-operative pain medication.

Cancer's growing commonness, Parkinson's disease, and rheumatic diseases drive the growth of the market. The use of oxycodone to relieve post-operative pain under different medical conditions fuels the growth of the market.

Increasing concern about oxycodone abuse, however, is curbing market growth. However, less addictive oxycodone drugs approved by the FDA for adults and children are likely to open new gateways in the forecast period for the growth of Oxycodone Market.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1286

Further key findings from the report suggest

• The Oxycodone Market is estimated to grow from USD 5.23 Billion in 2020 to USD 7.46 Billion by 2028, at a CAGR of 4.6%, during the forecast period. The oxycodone market is driven by an increase in the number of patients suffering from terminally ill diseases such as cancer and HIV and a high increase in the prescription of post-operative pain medication.
• The market for short acting oxycodone is expected to hold the largest market share at USD 5.09 Billion by 2028, at a CAGR of 5.5% during the forecast period. An increase in pharmaceutical companies new drug applications and the number of products in the pipeline are driving the market for oxycodone. Other formulations are coming up on the market, such as controlling the release of drugs to improve pain management.
• Based on routes of administration, the oral segment is expected to hold the largest market share and is expected to reach USD 2.98 Billion by 2028, at a CAGR of 5.8% during the forecast period. Oxycodone is only approved for mouth use in the United States, which is available as tablets and oral solutions. However, oxycodone parenteral formulations (brand name OxyNorm) are also available worldwide and are widely used in Europe.
• The market for hospital pharmacies is expected to reach USD 3.05 Billion by 2028, at a CAGR of 6.1% during the forecast period. The large scale development of specialty hospitals with increasing purchasing power is driving oxycodone products to be adopted more quickly. Another driver for the oxycodone market is the consolidation of large healthcare providers coupled with increased penetration of healthcare insurance.
• The market for North America is expected to reach USD 2.8 Billion by 2028, at a CAGR of 4.9% during the forecast period due to the increase in spending on healthcare market and the dominance of geriatric populations with terminal conditions such as rheumatoid arthritis is increasing, which will foster market growth.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1286

The report discusses in detail the top companies in the market along with their recent initiatives such as mergers and acquisitions, joint venture, partnerships, corporate and government deals, collaborations, and brand promotions and product launches among others. The report further discusses the companies’ initiatives and investments in key regions across the globe such as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.

Region analysis Covers

North America (U.S.A., Canada, Mexico)

Europe (U.K., Italy, Germany, France, Rest of Europe)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Segments covered in the report

This report forecasts volume and revenue growth at a global, regional & country level, and provides an analysis on the industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Reports and Data have segmented the market on the basis of type, routes of administration, application, distribution channel and regional analysis.

Type (Kilo Tons) (Revenue, USD Million; 2018-2028)

Short Acting Oxycodone

Long Acting Oxycodone

Routes of Administration (Kilo Tons) (Revenue, USD Million; 2018-2028)

Oral

Sublingual

Intramuscular

Intravenous

Intranasal

Subcutaneous

Transdermal

Rectal

Epidural

Distribution (Kilo Tons) (Revenue, USD Million; 2018-2028)

Hospital Pharmacies

Retail Pharmacies

Others

Application (Kilo Tons) (Revenue, USD Million; 2018-2028)

De-Addiction

Pain Management

To know more about the report @ https://www.reportsanddata.com/press-release/global-oxycodone-market

Top Companies operating in the Market and Profiled in the Report include:

Johnson & Johnson (US)

Sanofi (France)

Pfizer (US)

Purdue Pharma (US)

Endo International (Ireland)

Teva Pharmaceuticals (Israel)

Hikma Pharmaceuticals (UK)

Mallinckrodt (UK)

Mylan (US)

Sun Pharmaceutical (India)

Impax Laboratories (US)

Indivior (UK)

Others.

Read More Reports

Temperature Monitoring Systems Market @ https://www.biospace.com/article/temperature-monitoring-systems-market-to-reach-usd-6-6-billion-by-2028-says-reports-and-data/

Blood Preparation Market @ https://www.biospace.com/article/blood-preparation-market-to-reach-usd-63-57-billion-by-2028-says-reports-and-data/

Radiotherapy Market @ https://www.biospace.com/article/radiotherapy-market-size-to-reach-usd-11-08-billion-in-2028-says-reports-and-data/

Mammography Equipment Market @ https://www.biospace.com/article/mammography-equipment-market-to-reach-usd-5-63-billion-by-2028-says-reports-and-data/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:                                 

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

The global remote cardiac monitoring services market size is forecast to reach USD 10.97 Billion by 2028, registering a CAGR of 11.5% over the forecast period according to a new report by Reports and Data. Major factors driving market revenue growth are increase in prevalence of cardiovascular diseases (CVD), increasing incidence of obesity, lower cost of remote monitoring and rising geriatric population. Due to the rise in the rate of occurrence of CVD, remote cardiac monitoring services are becoming increasingly relevant in the healthcare sector.

A wide range of other applications such as detection, monitoring, and treatment of heart activities along with identifying abnormal heart rhythm has also contributed to the growth of remote cardiac monitoring services market.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1444

Increase in rate of occurrence of CVD has resulted in creating a burden on healthcare providing organizations. Such a burden has resulted in increased public and private investment in this industry. Due to the increase in investments, the industry is coming up with new services, that has impacted the growth of the industry positively. Remote cardiac monitoring services have enabled the transcending of geographic barrier for patients as well as for care providers. Such an increase in acceptance of the service has also contributed to the growth of remote cardiac monitoring services market.

Top Companies Profiled in the Report Include:

Preventice Solutions, Honeywell Life Care Solutions, Cardionet, Koninklijke Philips, Medtronic, Boston Scientific Corporation, Biotronik SE & Co. KG, Cardiac Science Corporation, Hill-Rom Holdings, Inc., LivaNova PLC, ReliantHeart Inc., St. Jude Medical, Inc, and Schiller AG.

Market Overview:

The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1444

Additionally, the report consists a detailed analysis of the segmentation of the Remote Cardiac Monitoring Services  market based on product types and end-use/application offered in the Remote Cardiac Monitoring Services  market.

Product Type Outlook (Revenue, USD Billion; 2020 – 2028)

• Cardiac Event Recorder
• Loop memory Monitor
• Symptom event monitor
• Holter Monitor
• Insertable Cardiac Monitor (ICM)
• Mobile Cardiac Telemetry Devices

Technology Outlook (Revenue, USD Billion; 2020 – 2028)

• Digital Health Technology
• Mobile Cardiac Telemetry Monitoring (MCT/MCOT)
• Artificial Intelligence
• AutoDetect Monitors
• Manual Event Monitor
• Smart Wearable ECG Monitors

Event Monitoring Outlook (Revenue, USD Billion; 2020 – 2028)

• Pre-Symptom (Memory Loop)
• Post-Symptom Event Monitor

Application Outlook (Revenue, USD Billion; 2020 – 2028)

• Coronary Artery Disease
• Arrhythmia
• Hypertension

End Use Outlook (Revenue, USD Billion; 2020 – 2028)

• Diagnostic Centers
• Hospitals
• Ambulatory Surgical Centers
• Academic and Research Institutions
• R&D Centers

Country-wise regional analysis covers:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Read More Reports :

Neuroendoscopy Market @ https://www.biospace.com/article/neuroendoscopy-market-to-reach-usd-278-2-million-by-2027-reports-and-data/

Nanoemulsions Market @ https://www.biospace.com/article/nanoemulsions-market-size-to-reach-usd-19-4-billion-by-2028-reports-and-data/

IoT in Healthcare Market @ https://www.biospace.com/article/iot-in-healthcare-market-to-reach-usd-260-75-billion-by-2027-reports-and-data/

Oxycodone Market @ https://www.biospace.com/article/oxycodone-market-size-to-reach-usd-7-49-billion-in-2028-says-reports-and-data/

Peptide Synthesis Market @ https://www.biospace.com/article/peptide-synthesis-market-size-to-reach-usd-516-75-million-in-2028-says-reports-and-data/

Primary Care Physicians Market @ https://www.reportsanddata.com/report-detail/primary-care-physicians-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:                       

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

To know more about the report @ https://www.reportsanddata.com/press-release/global-remote-cardiac-monitoring-services-market

The global NGS sample preparation market size is expected to reach USD 5.42 Billion by 2028 and register a CAGR of 19% over the forecast period, according to the latest report by Reports and Data. High adoption of NGS technology in diagnostics and development of cost-effective sequencing techniques are some key factors boosting market revenue growth.

Next generation sequencing technology helps in analyzing DNA and RNA sequence more accurately than other sequencing techniques, and involves less time and lower cost. Pre-sequencing methods help in generating high-quality and precise data more quickly. Factors such as increasing incidence of chronic diseases, genetic disorders, and cancer along with growing adoption of NGS sample preparation in molecular diagnostics and personalized medicine is augmenting growth of the NGS sample preparation market.

Top Companies Profiled in the Report Include:

Illumina Inc., Thermo Fisher Scientific, QIAGEN N.V., Agilent Technologies, Inc., Beckman Coulter, Becton, Dickinson and Company, Pacific Biosciences of California, Biomatters Ltd., Bio-Rad Laboratories, Inc., Congenica Ltd., DNASTAR, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Foundation Medicine, Genomatix GmbH, Macrogen, Myriad Genetics, Oxford Nanopore Technologies, Partek Incorporated, Perkin Elmer, and PierianDx.

To receive a sample copy of the global NGS Sample Preparation Market report, visit @ https://www.reportsanddata.com/download-summary-form/3987

NGS Sample Preparation Market Overview:

The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.

Major Highlights of the NGS Sample Preparation Market Report:

• On the basis of product type, the reagents & consumables segment is expected to account for significant revenue share during the forecast period owing to increase in NGS-based testing and availability of advanced and effective reagents, and precise tips and pipettes.
• Based on workflow, the library preparation segment is projected to account for relatively large revenue share during the forecast period owing to growing research and technological developments in NGS procedures for library preparation along with availability of a wide range of products.
• In context to technology, the Sequencing by Synthesis (SBS) segment is expected to emerge as the highest revenue contributing segment as this technology provides instant, precise DNA analysis, and whole-genome sequencing in a matter of hours.
• Based on application, the disease diagnostic segment is projected to account for high revenue growth during the forecast period, attributable to increasing prevalence of infectious diseases and cancer cases globally and existence of well-established market players who are investing to develop more efficient NGS products.
• Europe is expected to account for a significantly steady revenue growth rate between 2021 and 2028 due to increasing incidence of cancer, favorable reimbursement policies, and technological developments in NGS.
• Latin America is projected to account for steady revenue growth during the forecast period. Factors such as rising investments by key players and initiatives by governments are supporting market growth.

Additionally, the report consists a detailed analysis of the segmentation of the NGS Sample Preparation Market based on product types and end-use/application offered in the NGS Sample Preparation Market.

Based On Product Type (Revenue, USD Billion, 2018 – 2028)

• Workstations
• Reagents & Consumables

Based On Workflow (Revenue, USD Billion, 2018 – 2028)

• Reagents & Consumables
• Library Preparation
• DNA
• Human Whole Genome Sequencing (WGS)
• Targeted Sequencing
• Whole Exome Sequencing (WES)
• Others
• RNA
• Gene Expression Analysis
• Whole Transcriptome Sequencing
• Others
• Target Enrichment
• Targeted Seq
• WES
• Others
• Quality Control

Based On Technology (Revenue, USD Billion, 2018 – 2028)

• Sequencing by Synthesis (SBS)
• Ion Semiconductor Sequencing
• Single-molecule Real-time (SMRT) Sequencing
• Nanopore Sequencing
• Other Technologies

Based On Application (Revenue, USD Billion, 2018 – 2028)

• Disease Diagnostics
• Cancer Diagnostics
• Reproductive Health Diagnostics
• Infectious Disease Diagnostics
• Other Disease Diagnostic Applications
• Drug Discovery
• Agricultural and Animal Research
• Other Applications

Based On End Use (Revenue, USD Billion, 2018 – 2028)

• Academic Institutes and Research Centers
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Others

Key Regional Markets Studied in the Report:

• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• The Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

To know more about the NGS Sample Preparation Market report @ https://www.reportsanddata.com/report-detail/ngs-sample-preparation-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:                       

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Have A Look For Related Reports:

Dental X-Ray Market @ https://www.biospace.com/article/dental-x-ray-market-size-to-reach-usd-2085-95-million-in-2028-reports-and-data/

Insulin Delivery Devices Market @ https://www.biospace.com/article/insulin-delivery-devices-market-to-reach-usd-34-10-billion-by-2028-reports-and-data/

Medical/Diagnostic Imaging Market @ https://www.biospace.com/article/medical-diagnostic-imaging-market-to-reach-usd-37-02-billion-by-2027-reports-and-data/

Urological Devices Market @ https://www.biospace.com/article/urological-devices-market-to-reach-usd-62-76-billion-by-2027-reports-and-data/

Tomosynthesis Market @ https://www.biospace.com/article/tomosynthesis-market-to-reach-usd-3-70-billion-by-2026-reports-and-data/

Stereotactic Surgery Devices Market @ https://www.biospace.com/article/stereotactic-surgery-devices-market-to-reach-usd-24-73-billion-by-2027-reports-and-data/

The global next generation sequencing market was valued at USD 5,793.4 million in 2019 and is expected to reach USD 22.16 billion by the year 2027, at a CAGR of 15.9%. Next-generation sequencing non-Sanger based high throughput method of sequencing. Entire next generation sequencing methodology engages a wide range of reagents, kits, equipment, software and tools for the pieces of its entire workflow that includes sample preparation, library preparation & amplification, sequencing, and analysis. Due to the constant innovations in the NGS technologies, there has been a significant decline in the sequencing costs, complexity and turnaround time. Horizons of the NGS applications is expanding, which in turn offers ample opportunities to emerging as well the existing market players.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1868

Furthermore, increased government initiatives, availability of research funds from private as well as public bodies, improvement in the reimbursement scenario for NGS based diagnostics, and rising awareness about benefits of NGS technologies are among the key factors propelling the growth of next generation sequencing market.

Top Companies Profiled in the Report Include :

• Illumina, Inc. (U.S.)
• Thermo Fisher Scientific, Inc. (U.S.)
• Pacific Biosciences of California, Inc. (U.S.)
• Oxford Nanopore Technologies Ltd. (U.K.)
• BGI (China), PerkinElmer (U.S.)
• Agilent Technologies (U.S.)
• QIAGEN N. V. (Germany)
• Macrogen Inc. (South Korea)
• Eurofins Scientific (Luxembourg)

Further key findings from the report suggest :

• NGS platforms segment is expected to grow with a CAGR of 14.7% during the forecast period. Consumables remains the chief revenue generating segment in global next generation sequencing market
• Diagnosis of complex diseases, whole-genome sequencing, analysis of epigenetic modifications, mitochondrial sequencing, transcriptome sequencing, and exome sequencing, are among the key applications of NGS contributing to the market growth
• The volume of data generated from sequencing has significantly increased as a result of wide scale use of next generation sequencing. Consequently, the demand for NGS data analysis & data management tools & software is on surge
• RNA-Seq through next generation sequencing allows profiling of the entire transcriptome, including the coding and non-coding regions; and facilitates gene identification, provides information on their relative abundance, identification of novel transcripts, detection of other genetic variation
• Reduced costs and increased reliability of underlying NGS technologies has allowed next generation sequencing to flourish for research applications as well as healthcare applications such as clinical development, and clinical diagnostics
• North America remains the key revenue generating geographical segment in next generation sequencing market. The geographical segment accounted for USD 1.88 billion in 2019. Availability of research funds from public as well as private sources, availability of state-of-art technologies, presence of key market players in the region, favorable reimbursements for NGS based diagnostics, rising focus on precision medicine, and rising awareness about NGS applications, are among the key factors driving the market growth for next generation sequencing in this region

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1868

For the purpose of this report, Reports and Data has segmented the Next Generation Sequencing market on the basis of product and service, technology, application, end user and region:

Technology Outlook (Revenue in Million USD; 2017–2027)

• Sequencing by Synthesis (SBS)
• Ion Semiconductor Sequencing
• Single-molecule Real-time Sequencing (SMRT)
• Nanopore Sequencing
• Other Technologies

Application Outlook (Revenue in Million USD; 2017–2027)

• Diagnostics
• Cancer Diagnostics
• Infectious Disease Diagnostics
• Reproductive Health Diagnostics
• Other Diagnostic Applications
• Drug Discovery
• Agricultural and Animal Research
• Other Applications

End User Outlook (Revenue in Million USD; 2017–2027)

• Academia & Research Centers
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Other End Users

Key Regional Markets Studied in the Report:

• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• The Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Browse similar research reports :

Non-Small Cell Lung Cancer Market @ https://www.biospace.com/article/non-small-cell-lung-cancer-market-to-reach-usd-11-87-billion-by-2028-reports-and-data/

Photomedicine Market @ https://www.biospace.com/article/photomedicine-market-size-to-reach-usd-547-28-million-by-2028-reports-and-data/

Remote Cardiac Monitoring Services Market @ https://www.biospace.com/article/remote-cardiac-monitoring-services-market-to-reach-usd-1-55-billion-by-2028-reports-and-data/

Point of Care (PoC) Diagnostics Market @ https://www.biospace.com/article/rise-in-government-initiatives-to-address-overweight-issues-and-increasing-development-of-advanced-and-effective-weight-management-treatments-are-among-the-key-factors-contributing-to-market-growth/

Aneurysm Clips Market @ https://www.biospace.com/article/aneurysm-clips-market-to-reach-usd-1-74-billion-by-2027-reports-and-data/

Healthcare Cybersecurity Market @ https://www.biospace.com/article/healthcare-cybersecurity-market-size-to-reach-usd-36-97-billion-in-2028/

Colchicine Market @ https://www.biospace.com/article/colchicine-market-to-reach-usd-1-13-billion-by-2026-reports-and-data/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:                       

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Full Press Release @ https://www.reportsanddata.com/press-release/global-next-generation-sequencing-market

The global glucose meter market size is expected to reach USD 18.05 billion in 2028 and register a revenue CAGR of 9.4% over the forecast period, according to the latest report by Reports and Data. Market revenue growth is significantly spurred by surging demand for blood glucose meters among people with Type 1, Type 2, or gestational, or latent autoimmune diabetes. Other major factors prompting growth of the global glucose meter market are rise in global geriatric population, increasing prevalence of obesity and other lifestyle-induced conditions, rising demand for non-invasive glucose meters, and introduction of technologically advanced blood glucose meters with cutting-edge features and higher affordability. A glucose meter is a portable medical device that measures blood glucose levels in the body and is typically used by people suffering from diabetes for regular monitoring. Monitoring one’s blood sugar level on a regular basis is one of the most effective ways to keep the diseases under control, and it also helps the physician manage the condition better. Portable blood glucose meters, also referred to as glucometers, are increasingly being used by people for their highly convenient use.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/95

Some Key Highlights from the Report :

• Among product type segments, the continuous monitoring devices segment is projected to reach the largest revenue share over the forecast period. Growing prevalence of diabetes across the world, higher risk of the disease among geriatric people, surging need for constant glucose monitoring (CGM) devices, and increasing use of wearable CGM devices are among the key factors accounting for the growth of this segment.
• Based on type, the wearable segment will account for the highest revenue growth rate over the forecast period, owing to several favorable factors. Growing awareness about preventive care for diabetes, rising demand for advanced continuous glucose monitoring devices, and increasing use of smartphones and various fitness wearable devices are some of the factors boosting growth of this segment.
• Among regional markets, the North America glucose meter market accounted for the largest revenue share in 2020. High revenue growth of the regional market is supported by rising prevalence of lifestyle-induced diseases such as diabetes and obesity, growing use of blood glucose meters across home care settings, technological advances in glucometers, and increasing sales of wearable and self-monitoring glucose meters.

Top Companies Profiled in the Report Include:

Roche Diagnostics, Medtronic plc., Johnson and Johnson, Bayer AG, Abbott Laboratories, Omron, Arkray, Inc., Grace, B. Braun, i-SENS, Inc., DiaMonTech GmbH, Infopia Co., Ltd, Hainice Medical Inc., Mendor, All Medicus Co, Ltd, 77 Elektronika Kft, Delta Group, Ok Biotech, Medisana, Nova Biomedical, Oak Tree Health, Inc., Omnis Health, Simple Diagnostics, US Diagnostics, SD Biosensor, Nipro Diagnostics, Sannuo Biological Sensing Co. Ltd., Yuwell Medical, and Yicheng.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/95

For the purpose of this report, the global glucose meter market is segmented based on product, type, testing site, technique, application, distribution channel, and region:

Product Outlook (Revenue, USD Billion; 2018-2028)

• Self-monitoring Blood Glucose Systems
• Continuous Glucose Monitoring Systems

Type Outlook (Revenue, USD Billion; 2018-2028)

• Wearable
• Non-wearable

Testing Site Outlook (Revenue, USD Billion; 2018-2028)

• Fingertip Testing
• Alternate Site Testing

Technique Outlook (Revenue, USD Billion; 2018-2028)

• Invasive
• Non-invasive

Application Outlook (Revenue, USD Billion; 2018-2028)

• Hospitals
• Diagnostic Centers
• Home Care

Distribution Channel Outlook (Revenue, USD Billion; 2018-2028)

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Key Regional Markets Studied in the Report:

• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• The Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Browse similar research reports :

Biotechnology Market @ https://www.biospace.com/article/biotechnology-market-to-reach-usd-1-029-09-billion-by-2027-reports-and-data/

Tissue Engineering Market @ https://www.biospace.com/article/tissue-engineering-market-to-reach-usd-26-11-billion-by-2027-reports-and-data/

Exoskeleton Market @ https://www.biospace.com/article/exoskeleton-market-to-reach-usd-8-21-billion-by-2028-reports-and-data/

Biochip Market @ https://www.biospace.com/article/biochip-market-to-reach-usd-29-90-billion-by-2028-reports-and-data/

Clinical Laboratory Market @ https://www.biospace.com/article/clinical-laboratory-market-size-to-reach-usd-391-14-billion-in-2028-reports-and-data/

Non-Small Cell Lung Cancer Market @ https://www.biospace.com/article/non-small-cell-lung-cancer-market-to-reach-usd-11-87-billion-by-2028-reports-and-data/

Photomedicine Market @ https://www.biospace.com/article/photomedicine-market-size-to-reach-usd-547-28-million-by-2028-reports-and-data/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:                       

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Full Press Release @ https://www.reportsanddata.com/press-release/global-glucose-meter-market

The Global Non-Small Cell Lung Cancer Market size is forecast to reach USD 11.87 Billion by 2028, registering a CAGR of 6.2% over the forecast period, according to a new report by Reports and Data. Major factors driving market revenue growth is the introduction of immune checkpoint inhibitors (ICIs) into the first-line context. Non small cell lung cancer accounts for 80 percent to 85 percent of all lung cancer cases across the world, and this high proportion has prompted the majority of market leaders to focus on constant innovation of new therapies and improving the efficacy of existing medicines. The market growth is also owing to lung cancer’s reputation as one of the most common malignancies, contributing to a considerable number of deaths globally. The expansion of the non small cell lung cancer market is further aided by an increase in the frequency of diagnosis of non small cell lung cancer and increased awareness about the disease in developed and emerging countries. This, combined with increased spending by leading companies in research and development operations, as well as the inclusion of non-small cell cancer therapies in major market participants’ pipelines, is fueling global market expansion.

Top Companies Profiled in the Report Include:

Tarceva,

Avastin,

Gemzar,

Alimta,

Taxotere,

AstraZeneca,

Roche,

Merck KGa,

Nlyte,

Panduit Corp.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1475

Market Overview:

The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1475

The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, RD activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.

The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Non-Small Cell Lung Cancer market in these key regions.

Country-wise regional analysis covers:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East Africa

To know more about the report @ https://www.reportsanddata.com/press-release/global-non-small-cell-lung-cancer-market

Additionally, the report consists a detailed analysis of the segmentation of the Non-Small Cell Lung Cancer market based on product types and end-use/application offered in the Non-Small Cell Lung Cancer market.

Histology Outlook (Revenue, USD Billion; 2018 – 2028)

• Squamous Cell Carcinoma
• Large Cell Carcinoma
• Adenocarcinoma

Treatment Outlook (Revenue, USD Billion; 2018 – 2028)

• Surgery
• Radiation
• Chemotherapy
• Targeted Therapy Drugs

Drug Class Outlook (Revenue, USD Billion; 2018 – 2028)

• Angiogenesis Inhibitor
• Epidermal Growth Factor Receptor Blocker
• Kinase Inhibitor
• Microtubule Stabilizer
• Folate Antimetabolites
• PD-1/ PD-L1 Inhibitor

Read More Reports –

Biosimilars Market @ https://www.biospace.com/article/biosimilars-market-size-to-reach-usd-69-07-billion-in-2028-noted-reports-and-data/

Heart Failure POC & LOC Devices Market @ https://www.biospace.com/article/heart-failure-poc-and-loc-devices-market-size-to-reach-usd-209-5-million-in-2028-noted-reports-and-data/

Structural Heart Imaging Market @ https://www.biospace.com/article/structural-heart-imaging-market-size-to-reach-usd-34-1-billion-in-2028-noted-reports-and-data/

Hepatitis Diagnostic Test Market @ https://www.biospace.com/article/hepatitis-diagnostic-test-market-to-reach-usd-8-4-billion-in-2028-noted-reports-and-data/

Dental Lasers Market @ https://www.biospace.com/article/dental-lasers-market-size-to-reach-usd-345-1-million-in-2028-noted-reports-and-data/

Aminoglycosides Market @ https://www.biospace.com/article/aminoglycosides-market-size-to-reach-usd-2-16-billion-by-2028-reports-and-data/

Artificial Intelligence In Healthcare Market @ https://www.biospace.com/article/artificial-intelligence-in-healthcare-market-to-reach-usd-61-59-billion-by-2027-reports-and-data/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

The global epinephrine market size is expected to reach USD 4.76 Billion by 2028 at a CAGR of 8.7%, according to the latest report by Reports and Data. Increasing demand for auto-injectors owing to their quick administration during emergency situations, increasing incidence of severe allergic reactions and anaphylactic shock, and technological advancements in epinephrine injectors are key factors expected to drive market revenue growth over the forecast period. Epinephrine is widely used to restore cardiac rhythm, control asthma, and treat life-threatening allergic reactions. This is also a key factor boosting demand for epinephrine products and is expected to contribute to market growth going ahead.

To receive a sample copy of the global Epinephrine Market report, visit @ https://www.reportsanddata.com/download-summary-form/91

Epinephrine, or adrenaline, is a hormone and neurotransmitter having vasoconstricting, intraocular pressure-reducing, and bronchodilating activities. Epinephrine is one of the most widely used agents as it can function both as a medication and hormone. Epinephrine has been approved by the FDA for the treatment of type 1 hypersensitivity reaction, cardiac arrest, and asthma attacks and also has several off-label uses. Epinephrine plays an important role in fight-or-flight response by increasing blood flow to muscles. Based on the diagnosis, epinephrine administration varies such as it can be given intravenously, injection into muscles, by inhalation, or by injecting just under the skin.

Top Companies Profiled in the Report Include:

• Abbott Laboratories
• Lincoln Medical Ltd.
• Mylan Inc.
• Sanofi SA
• Amedra Pharmaceuticals LLC
• ALK Abello A/S.

Some Key Highlights from the Report :

• Epinephrine auto-injector segment is expected to register significant revenue growth over the forecast period owing to growing demand for prefilled auto-injectors due to its quick response, launch of affordable generic epinephrine products, and innovations in auto-injectors.
• Anaphylaxis segment is expected to account for a significant share in the global market owing to increasing incidence of anaphylactic allergic reactions and increasing number of people susceptible to allergies. Epinephrine is primary treatment approach for anaphylaxis.
• North America is expected to account for largest revenue share in the global market owing to increasing number of people with life-threatening food allergies, rise in chronic illnesses due to allergies, presence of robust healthcare facilities, and rapid launch of advanced epinephrine injections and products.
• In June 2021, Alerje Inc., which is a food allergy management company based in Detroit, introduced a smartphone case equipped with auto-injector that rapidly releases epinephrine during severe allergic reactions. It will also automatically alter the patients’ support circle through Alerje smartphone app when a dose is discharged from the case.

Major Highlights of the Epinephrine Market Report:

• The Epinephrine Market analysis report offers an in-depth study of the potential market growth opportunities and challenges.
• The report dives deeper into the market and explains the dynamic factors bolstering market growth.
• The report deeply assesses the current, historical market size, market share, and revenue growth rates to offer accurate market projections for the forecast period.
• The report analyzes the Epinephrine Market presence across major regions of the world.
• It determines the production & consumption capacities and demand & supply dynamics of each regional market.
• The report further illustrates the intense competition among the key market players and highlights their effective business expansion plans and strategies.
• It provides company overview and SWOT analysis of each of the market players.

To receive a flat discount on the Epinephrine Market report, visit @ https://www.reportsanddata.com/discount-enquiry-form/91

For the purpose of this report, Reports and Data has segmented the global epinephrine market on the basis of type, application, and region :

Type Outlook (Revenue, USD Million; Volume, Tons, 2018–2028)

• Epinephrine Auto-injector
• Epinephrine Prefilled Syringe
• Others

Application Outlook (Revenue, USD Million; Volume, Tons, 2018–2028)

• Anaphylaxis
• Others

Key Regional Markets Studied in the Report

• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• The Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

To know more about the Epinephrine Market report @ https://www.reportsanddata.com/report-detail/epinephrine-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.  

Have A Look For Related Reports:

Zika Virus Testing Market @ https://www.biospace.com/article/zika-virus-testing-market-to-reach-usd-328-3-million-in-2028-says-reports-and-data/

Disruptive Behavior Disorder Treatment Market @ https://www.biospace.com/article/disruptive-behavior-disorder-treatment-market-size-to-reach-usd-26-3-billion-in-2028-says-reports-and-data/

Hematology Diagnostics Market @ https://www.biospace.com/article/hematology-diagnostics-market-size-to-reach-usd-11-16-billion-in-2028-says-reports-and-data/

Digital Radiography Market @ https://www.biospace.com/article/digital-radiography-market-size-to-reach-usd-19-82-billion-in-2028-says-reports-and-data/

Lateral Flow Assays Market @ https://www.biospace.com/article/lateral-flow-assays-market-size-to-value-at-usd-11-66-billion-in-2028-noted-reports-and-data/

Cell Viability Assays Market @ https://www.biospace.com/article/cell-viability-assays-market-size-to-reach-usd-6-35-billion-in-2028-says-reports-and-data-/

The Global Non-Small Cell Lung Cancer Market size is forecast to reach USD 11.87 Billion by 2028, registering a CAGR of 6.2% over the forecast period, according to a new report by Reports and Data. Major factors driving market revenue growth is the introduction of immune checkpoint inhibitors (ICIs) into the first-line context. Non small cell lung cancer accounts for 80 percent to 85 percent of all lung cancer cases across the world, and this high proportion has prompted the majority of market leaders to focus on constant innovation of new therapies and improving the efficacy of existing medicines. The market growth is also owing to lung cancer’s reputation as one of the most common malignancies, contributing to a considerable number of deaths globally. The expansion of the non small cell lung cancer market is further aided by an increase in the frequency of diagnosis of non small cell lung cancer and increased awareness about the disease in developed and emerging countries. This, combined with increased spending by leading companies in research and development operations, as well as the inclusion of non-small cell cancer therapies in major market participants’ pipelines, is fueling global market expansion.

Top Companies Profiled in the Report Include:

Tarceva,

Avastin,

Gemzar,

Alimta,

Taxotere,

AstraZeneca,

Roche,

Merck KGa,

Nlyte,

Panduit Corp,

others.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1475

Market Overview:

The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1475

The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.

The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Non-Small Cell Lung Cancer market in these key regions.

Country-wise regional analysis covers:

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• BENELUX
• Italy
• Spain
• Switzerland
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of APAC
• Latin America
• Brazil
• Rest of LATAM
• Middle East & Africa
• Saudi Arabia
• U.A.E.
• South Africa
• Turkey
• Rest of MEA

To know more about the report @ https://www.reportsanddata.com/press-release/global-non-small-cell-lung-cancer-market

Additionally, the report consists a detailed analysis of the segmentation of the Non-Small Cell Lung Cancer market based on product types and end-use/application offered in the Non-Small Cell Lung Cancer market.

Histology Outlook (Revenue, USD Billion; 2018 – 2028)

• Squamous Cell Carcinoma
• Large Cell Carcinoma
• Adenocarcinoma

Treatment Outlook (Revenue, USD Billion; 2018 – 2028)

• Surgery
• Radiation
• Chemotherapy
• Targeted Therapy Drugs

Drug Class Outlook (Revenue, USD Billion; 2018 – 2028)

• Angiogenesis Inhibitor
• Epidermal Growth Factor Receptor Blocker
• Kinase Inhibitor
• Microtubule Stabilizer
• Folate Antimetabolites
• PD-1/ PD-L1 Inhibitor

Read More Reports -

Protein Binding Assays Market @ https://www.biospace.com/article/protein-binding-assays-market-size-to-reach-usd-710-8-million-in-2028/

Primary Care POC Diagnostics Market @ https://www.biospace.com/article/primary-care-poc-diagnostics-market-size-to-reach-usd-9-5-billion-in-2028-says-reports-and-data/

Neuroscience Antibodies and Assays Market @ https://www.biospace.com/article/neuroscience-antibodies-and-assays-market-size-to-reach-usd-7-06-billion-in-2028-says-reports-and-data-/

Clinical Microbiology Market @ https://www.biospace.com/article/clinical-microbiology-market-size-to-reach-usd-6-6-billion-in-2028-noted-reports-and-data/

Bioresorbable Medical Material Market @ https://www.biospace.com/article/bioresorbable-medical-material-market-size-to-reach-usd-2-193-01-million-in-2028-says-reports-and-data/

Epinephrine Market @ https://www.biospace.com/article/epinephrine-market-size-to-reach-usd-4-76-billion-in-2028-says-reports-and-data/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Reports and Data has recently added a new comprehensive research report on the global Blood Pressure Monitoring Device market with key details about market share, market size, market revenue growth, CAGR, and other vital statistical data for the forecast period of 2021-2028. The report is furnished with valuable insights gathered from extensive primary and secondary research and further validated from industry experts and professionals. The report segments the global Blood Pressure Monitoring Device based on type, application, end-use, and regions. The report leverages robust bottom-up and top-down approaches to provide crucial insights about the market including historical and forecast data. The report provides a comprehensive overview of key initiatives and strategies adopted by the key market players to increase their revenue growth and gain a robust footing in the market.

Top Companies Profiled in the Report Include:

• Omron Healthcare, Inc. 
• Hill-Rom Holdings, Inc.
• Nihon Kohden Corporation
• Koninklijke Philips N.V. 
• Masimo
• Beurer GmbH 
• GE Healthcare (General Electric Company)
• American Diagnostic Corporation
• SunTech Medical, Inc.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4376

Market Overview:

The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.  

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4376

The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.

The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Blood Pressure Monitoring Device market in these key regions.

Country-wise regional analysis covers:

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East & Africa

Additionally, the report consists a detailed analysis of the segmentation of the Blood Pressure Monitoring Device market based on product types and end-use/application offered in the Blood Pressure Monitoring Device market.

Product Type Outlook (Revenue, USD Billion; 2018-2028)

• Aneroid BP Monitors
• Digital BP Monitors
• Blood Pressure Instrument Accessories
• Ambulatory BP Monitors
• Automated BP Monitors
• Sphygmomanometers
• Others

End-Use Outlook (Revenue, USD Billion; 2018-2028)

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Home Setting
• Others

Read More Reports –

Surgical Needle Market - https://www.reportsanddata.com/report-detail/surgical-needle-market

Protein Binding Assays Market - https://www.reportsanddata.com/report-detail/protein-binding-assays-market

Cell Sorting Market - https://www.reportsanddata.com/report-detail/cell-sorting-market

Galantamine Hydrobromide Market - https://www.reportsanddata.com/report-detail/galantamine-hydrobromide-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:                                 

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

To know more about the report @ https://www.reportsanddata.com/report-detail/blood-pressure-monitoring-device-market